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Abstract
Posterior capsule opacification (PCO) commonly develops
following cataract surgery and is a wound-healing response
that can ultimately lead to secondary visual loss. Improved
management of this problem is required. The isothiocyanate,
sulforaphane (SFN), is reported to exert cytoprotective and
cytotoxic actions, and the latter may be exploited to treat/
prevent PCO. SFN concentrations of 10 μM and above sig-
nificantly impaired wound-healing in a human lens capsular
bag model. A similar pattern of response was also seen with a
human lens cell line, FHL124. SFN treatment promoted in-
creased expression of endoplasmic reticulum (ER) stress
genes, which also corresponded with protein expression.
Evidence of autophagy was observed in response to SFN as
determined by increased microtubule-associated protein 1A/
1B-light chain 3 (LC3)-II levels and detection of autophagic
vesicles. This response was disrupted by established autoph-
agy inhibitors chloroquine and 3-MA. SFN was found to pro-
mote MAPK signaling, and inhibition of ERK activation
using U0126 prevented SFN-induced LC3-II elevation and
vesicle formation. SFN also significantly increased levels of
reactive oxygen species. Taken together, our findings suggest
that SFN is capable of reducing lens cell growth and viability
and thus could serve as a putative therapeutic agent for PCO.
Key message
& SFN reduces lens epithelial cell growth, migration, and
viability.
& SFN can promote ER stress and autophagy in lens cells.
& SFN promotes MAPK signaling, and inhibition of MEK
can suppress SFN-induced autophagy.
& ER stress and autophagy in lens cells are likely promoted
by ROS production.
& SFN may help prevent posterior capsule opacification af-
ter cataract surgery.
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Introduction
Cataract renders millions of people blind throughout the
world. Despite recent advances in putative cataract treatments,
the only currently accepted means of resolving the problem is
through surgical intervention [1, 2]. Cataract removal is the
most common surgical procedure in the world and is a huge
drain on healthcare providers [3, 4]. Posterior capsule
opacification (PCO) is the most common complication of cat-
aract surgery and likely the most common cause of
nonrefractive decreased postoperative vision [5, 6]. PCO oc-
curs in a significant proportion of cataract surgery patients
within 5 years postoperatively, depending on age, geographic
location, and the type of intraocular lens (IOL) placed during
cataract surgery [2, 7]. PCO reflects the wound-healing pro-
cess of the lens epithelial cells (LECs) that remain in the cap-
sular bag after cataract surgery. Residual LECs within the
capsular bag rapidly grow and proliferate across the posterior
lens capsule, which can encroach upon the visual axis and
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cause a secondary reduction in vision quality [8]. Treatment of
PCO is usually straightforward and effective, using the
neodymium:YAG (Nd:YAG) laser to cut an opening in the
posterior lens capsule, thus clearing the visual axis and restor-
ing vision [2]. However, disruption of the posterior capsule
due to complications of cataract surgery results in a relative
increase in the occurrence of complications such as an eleva-
tion in intraocular pressure, retinal cystoid macular edema,
glaucoma, intraocular lens damage, iritis, endophthalmitis,
and retinal detachment [9]. Nd:YAG treatment is the second
most common corrective surgery, which provides further cost
to healthcare providers not to mention the reduced quality of
life experienced by the patient as PCO develops. Thus, PCO is
an important problem, and thus, improvedmanagement of this
condition is required. A number of strategies have been pro-
posed but are yet to reach the clinic. These include mechanical
approaches, which strive to remove all LECs during surgery
or by altering shape and materials of the IOL designs [10, 11].
Different pharmaceutical methods to prevent PCO by remov-
ing or destroying residual LECs have also been proposed that
can either arrest growth, prevent matrix contraction, or destroy
the entire lens cell population [12–15].
In the present study, we investigated sulforaphane [1-
isothiocyanato-4-(methylsulfinyl)-butane, sulforaphane
(SFN)] in the prevention of PCO. SFN is an organic isothio-
cyanate that is derived from glucosinolates found in crucifer-
ous vegetables [16]. SFN is an intriguing molecule as it is
reported to play a role in both cytoprotection and cytotoxicity.
These contrasting outcomes are governed by concentration,
such that a threshold is eventually reached that is associated
with reduced cell viability and death. In the lens, we have
previously shown that low micromolar concentrations of
SFN do not reduce cell viability or promote cell death [17].
At these lower concentrations, Nrf2 signaling is activated,
which leads to increased expression of antioxidant response
proteins and thus better prepares cells to manage oxidative
stress. Similar responses have also been observed in other
cells and tissue [16]. SFN was also found to prevent oxidative
stress-induced opacity of cultured whole lenses [17]. With
respect to cytotoxic actions of SFN, it has been reported to
inhibit tumor growth in many in vivo models by inducing cell
cycle arrest and instigating apoptosis [18, 19]. Also, SFN has
been proposed to reduce proliferation and promote cell death
via ROS generation [20, 21].
In the present study, we aimed to assess whether SFN could
reduce cell growth and promote cell death using a human
tissue culture model and a human lens cell line, using them
as a tool to identify mechanisms that drive these different
cellular outcomes. In particular, we elected to investigate the
potential involvement of endoplasmic reticulum (ER) stress
pathways [22, 23] and autophagy [24, 25]. ER stress is report-
ed to be enhanced by SFN [26, 27]. Similarly, SFN can also
initiate autophagy in several cell types [28], which in addition
to its housekeeping role can also contribute to cell death in
certain circumstances [29]. Our investigation revealed a cyto-
toxic action of SFN in our human lens capsular bag model,
which is an excellent predictive tool for clinical outcomes.
Using a human lens cell line, we also identified that SFN
can promote ER stress and autophagy in human lens cells.
In the case of autophagy, SFN-mediated MAPK signaling
appears to play an important role.
Materials and methods
Human lens capsular bag preparation
Simulated cataract operations were performed to create cap-
sular bags from human donor lenses [30] that were obtained
with informed consent and used in accordance with the tenets
of the Declaration of Helsinki. Approval for the study and
experimental protocols (04/Q0102/57) was granted by a na-
tional research ethics committee under the Health Research
Authority (UK). Using an insulin needle, the anterior capsule
was breached approximately 3 mm from the equator, and an
incision was made from that point to the center of the capsule.
By tugging the flap, created by this incision, with surgical
forceps, a continuous curvilinear capsulorhexis was created,
such that a disc of anterior capsule was removed, leaving an
opening approximately 5 mm in diameter. The resultant win-
dow enabled the lens fiber mass to be removed by
hydroexpression. Residual fibers were removed by joint irri-
gation with Hartmann’s solution and aspiration. The resultant
capsular bag was then dissected free of the zonules and se-
cured on a sterile 35-mm polymethylmethacrylate (PMMA)
Petri dish. Eight entomological pins (Anglian Lepidopterist
Supplies, Hindolveston, Norfolk, UK) were inserted through
the edge of the capsule to retain its circular shape. Capsular
bags were maintained in 1.5 mL Eagle’s minimum essential
medium (EMEM) (Sigma-Aldrich, Poole, UK) and incubated
at 35 °C in a 5% CO2 atmosphere. Preparations were exposed
to 0, 1, 10, or 100 μM SFN for the first 24 h of culture and
then maintained in unsupplemented EMEM for the remaining
experimental period (end point at 30 days). Ongoing observa-
tions were made using a Nikon phase-contrast microscope
(Nikon, Tokyo, Japan).
FHL124 human lens cell line
FHL124 is a nonvirally transformed cell line generated from
human capsule-epithelial explants, showing a 99.5% homol-
ogy (in transcript profile) with the native lens epithelium [31].
FHL124 cells were routinely cultured at 35 °C in a humidified
atmosphere of 95% air and 5% CO2, in EMEM supplemented
with 5% fetal calf serum (FCS) (Gibco, Paisley, UK) and
50 μg/mL gentamicin (Sigma-Aldrich). FHL124 cells were
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seeded on the following: 35-mm tissue culture dishes (30,000/
dish for Western blot, qRT-PCR, TEM, and scratch migration
assay), coverslips (10,000) for immunocytochemistry, and 96-
well plates (5000/well for MTS (3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazoli-
um) assay and ROS detection assay (Promega, Madison, WI)
and lactate dehydrogenase (LDH) assay (Roche).
Cell viability
A cell proliferation assay (CellTiter 96 AQueous; Promega) was
used in accordance with the manufacturer’s instructions to as-
sess FHL124 cell viability. This assay is a colorimetric method
for determining the number of viable cells in proliferation. The
assay is based on the cellular conversion of a tetrazolium salt
(MTS) into a formazan product. The resultant absorbance is
directly proportional to the number of viable cells in culture.
Absorbance was measured at 490 nmwith a spectrophotometric
plate reader (FLUOstar Omega plate reader; BMG Labtech).
Cell death assay
A nonradioactive cytotoxicity assay (CytoTox 96R; Roche,
Welwyn Garden City, UK) was used to measure the release
of LDH from cultured human lens cells. The procedure
followed the manufacturer’s protocol. The plate was read at
490 nmwith a FLUOstar Omega plate reader (BMGLabtech).
Scratch wound assay
FHL124 cells in each well were allowed to grow to 95%
confluence. Cells were then placed in unsupplemented
EMEM for a 24-h period. A scratch was made through the
sheet of cells using a plastic pipette tip. Photomicrographs
were taken immediately after the scratch was made and after
24 h of incubation in experimental conditions. ImageJ1.45s
analysis software (available in the public domain at
http://rsbweb.nih.gov/ij/) was then used to quantify the
initial scratch area and the final area of the scratch.
TaqMan qRT-PCR
qRT-PCR reactions were performed using an ABI prism 7700
Sequence Detection System (Applied Biosystems,
Warrington, UK) under the following conditions: 50 °C for
2 min, 95 °C for 10min, and then 40 cycles, each consisting of
15 s at 95 °C and 1 min at 60 °C. Each reaction was performed
in 25μL and contained reverse transcribed RNA, primers, and
probes (sequences for primers and probes are given in Table 1)
and TaqMan PCR master mix (Applied Biosystems). Primers
and probes were bought as predesigned TaqMan probe and
primer sets provided by Applied Biosystems. The threshold
cycle (Ct) values, defined as the point at which the fluorescent
signal is recorded as statistically above background, were ob-
tained using the 7500 Fast system software 2.0.5 (Applied
Biosystems).
Immunoblotting
Cell lysates from FHL124 cells were prepared using Daub’s
lysis buffer supplemented with 1 mM phenylmethylsulfonyl
fluoride (PMSF) and 10 μg/mL aprotinin for 20 min on ice
and centrifuged at 16,060×g for 10 min. The protein content
was determined by the BCA assay (Bio-Rad, Hemel
Hempstead, UK) so that equal amounts of protein per sample
were loaded onto 8% SDS–polyacrylamide gels and trans-
ferred to PVDF membrane using a semidry transfer cell. The
membrane was blocked with PBS containing 5% nonfat dry
milk and 0.1% Tween-20, hybridized with primary antibody
(anti-LC3, (Sigma-Aldrich, Poole, Dorset); anti-ERK, anti-
JNK, anti-p38, anti-β-actin (Cell Signaling Technology,
Beverly, MA, USA), anti-EIF-2α, anti-BiP/GRP78
(BioSource International, Rockville, MD); anti-IRE1, anti-
ATF6 (Abcam, Cambridge, UK)) followed by incubation with
secondary antibody (Amersham Biosciences, Bucks, UK).
Proteins were detected using the ECL plus blotting analysis
system (Amersham Biosciences).
Transmission electron microscopy
Cultured FHL124 were treated with 100 μM SFN for 24 h
(n = 4) to fixation with 3% gluteraldehyde in 0.1 M phosphate
buffer (pH 7.2) and 2% paraformaldehyde (PFA) for 24 h.
Following fixation, samples were post-fixed in 1% OsO4 in
the same buffer for 30 min. Appropriate areas for thin section-
ing were cut at 70 nm and stained with saturated 2% uranyl
acetate and 2% lead citrate before examination on a transmis-
sion electron microscope (Libra 120, Carl Zeiss) at 120 kV.
Immunofluorescence
Cells were maintained in unsupplemented EMEM for 24 h
before being placed in experimental conditions for selected
periods. Cells were fixed with 4% formaldehyde in PBS for
30 min and permeabilized with PBS containing 0.5% Triton
X-100 for 30 min. Preparations were washed three times for
Table 1 Predesigned TaqMan probe/primer sets for genes of interest
Gene name Protein encoded Ref seq TaqMan primer/
probe set
AFT6 AFT6 NM_007348 Hs00232586_m1
ERN1 IRE1 NM_001433 Hs00176385_m1
EIF2AK3 EIF2α NM_003836.3 Hs00178128_m1
HSPA5 BiP NM_004836.3 Hs99999174_m1
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5 min in PBS containing 0.02% w/v BSA and 0.05% v/v
IGEPAL. Nonspecific sites were blocked with normal goat
or donkey serum (1:50 in 1% w/v BSA in PBS). Following
removal of the blocking buffer, rabbit polyclonal primary an-
tibody against microtubule-associated protein 1A/1B-light chain
3 (LC3) (Sigma-Aldrich, Poole, Dorset) diluted 1:200 was ap-
plied overnight at 4 °C. Cells were subsequently washed with
PBS and placed in ALEXA-488 conjugated secondary antibody
(1:250; Invitrogen) for 1 h at room temperature. The stained
preparations were again washed extensively and mounted on
microscope slides with Hydromount mounting medium
(National Diagnostics, Hull, UK). Images were viewed using
fluorescence microscopy (Axioplan 2; Zeiss), and applicable
images were quantified using ImageJ1.45s analysis software
(available in the public domain at http://rsbweb.nih.gov/ij/).
ROS detection assay
ROS levels were measured using a cellular reactive oxygen
species detection assay (Abcam, UK) that uses the cell
permeant reagent 2′,7 ′-dichlorofluorescin diacetate
(DCFDA) to measure hydroxyl, peroxyl, and other ROS ac-
tivities. This was in accordance with manufacturer instruc-
tions. The cells were washed with buffer before being stained
with 20 μM DCFDA for 45 min at 37 °C, and then washed
with buffer again before addition of EMEM and test com-
pounds. The fluorescence (excitation/emission was 485/
535 nm, respectively) was then measured following a 2-h
incubation.
Statistical analysis
A Student’s t test analysis was performed using Excel soft-
ware (Microsoft, Redmond, WA) to determine any statistical
difference between two groups. One-way ANOVA with
Tukey’s post hoc analysis was used to assess multiple groups
when all or many pairwise comparisons were of interest. One-
way ANOVA with Dunnett’s post hoc analysis was used to
assess all groups compared against the control group. A 95%
confidence interval was used to assess significance.
Results
SFN can reduce lens cell coverage and promote cell death
Capsular bags maintained in standard serum-free culture con-
ditions demonstrated progressive cell growth across denuded
regions of the anterior capsule, the outer anterior capsule, and,
importantly, the previously cell-free posterior capsule. At day
8, cells could be clearly seen on the central posterior capsule.
The level of growth in capsular bag preparations treated with
1 μM SFN for the first 24-h period of culture was similar to
control preparations (Fig. 1a, b). Cells were also observed on
the central posterior capsule with 10μMSFN, but growth was
retarded (Fig. 1a, b). Limited coverage of the central posterior
capsule was seen with 100 μM SFN, and indeed, the cells on
the anterior capsule appeared distressed at this time point
(Fig. 1a, b). Following 30 days of culture (end point), control
capsular bags exhibited complete coverage of the posterior
capsule (Fig. 1c, d). Exposure to 1 μM SFN for the first
24 h of culture had negligible effect on cell coverage by day
30 (Fig. 1c, d). Capsular bags exposed to 10 μMSFN for 24 h
demonstrated a marked reduction in cells growing on the pos-
terior capsule, and 24-h treatment with 100 μM SFN leads to
widespread cell death and completely inhibited coverage of
the posterior capsule (Fig. 1c, d).
Previous work has shown that SFN can reduce cell viability
and induce death (by apoptosis) of FHL124 cells [17]; this
was determined using the ApoTox-Glo Triplex assay
(Promega). In the current study, we verified this response
using different biochemical assays. The MTS assay was used
to assess cell viability, and it was found that SFN reduced cell
viability in a concentration-dependent manner, such that sig-
nificant differences from control were seen with treatments at
10 μM and above (Fig. 1e). Cell damage/death was observed
using the LDH assay, and in this case, significant increases in
LDH levels were detected with 10-, 30-, and 100-μM treat-
ments (Fig.1f).
We further assessed the impact of SFN on wound-healing
of FHL124 cells using the scratch assay method. Following
wound formation, control and 1 μM SFN-treated cells were
seen to close the denuded region at similar rates. However,
significant inhibition of wound closure was observed with
10-, 30-, and 100-μM SFN treatments (Fig. 1g).
The findings with the cell line demonstrate that this system
is a relevant model to study SFN in relation to PCO and lens
cell behavior. We therefore employed this biological tool to
further investigate the mechanisms governed by SFN that
could contribute to abrogation in the wound-healing response.
Promotion of ER stress pathways by SFN
In order to investigate the putative involvement of ER stress in
SFN-mediated events, real-time PCR and Western blot analy-
sis were employed. FHL124 cells were treated with 10, 30,
and 100 μM SFN for 24 h. Real-time PCR revealed increases
in all four ER stress gene products tested in FHL124 cells after
exposure to SFN for 24 h (Fig. 2). The level of the inositol-
requiring enzyme 1 (IRE1) gene (ERN1) in lens cells was
significantly increased within 24 h of exposure to 30 μM
SFN (Fig. 2d). All genes were significantly elevated at
100 μM SFN (Fig. 2a–d). At the protein level, binding immu-
noglobulin protein (BiP), activating transcription factor 6
(ATF6), eukaryotic translation initiation factor 2α (EIF2α),
and IRE1 were significantly upregulated in response to a
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Fig. 2 SFN can induce ER stress in FHL124 human lens epithelial cells.
Gene expression of a EIF2AK3, b ATF6, c HSPA5, and d ERN1
following 24-h exposure to SFN concentrations, detected by real-time
PCR. Values were normalized to 18S gene expression. The data
represent mean ± SEM (n = 4). Asterisk represents a significant
difference between untreated control and treated groups (p ≤ 0.05;
ANOVA with Dunnett’s post hoc test). Detection of ER stress proteins
in response to SFN was determined using Western blot methods. e
Representative blots showing BiP, ATF6, IRE1, EIF2α, and β-actin
levels within FHL124 cells; product bands were observed at ∼78, 75,
107, 36, and 45 kDa, respectively. f Quantitative data derived from
band intensities; the protein band intensities for BiP, ATF6, IRE1, and
EIF2α were normalized to β-actin. Data are presented as mean ± SEM
(n = 4). Asterisk indicates a significant difference between treated and
nontreated control groups (p ≤ 0.05; ANOVA with Dunnett’s post hoc
test)
Fig. 1 The effect of SFN on cell survival and growth of human lens cells.
Modified dark-field images of four human capsular bag quarters showing
the posterior capsule (PC), capsulorhexis (arrowed), and outer anterior
capsule (AC) captured after a 8 and c 30 days. Cell coverage on the
posterior capsule was quantified from dark-field images at b 8 and d
30 days. Data are presented as mean ± SEM (n = 4). Asterisk indicates
a significant difference between treated and control groups. The effects of
SFN exposure to FHL124 cells over a 24-h period on e cell viability, f cell
death, and gmigration assessed using theMTS, LDH, and scratch wound
assays, respectively. The data are presented as mean ± SEM of four
independent experiments. Asterisk represents a significant difference
between untreated control and treatment groups (p ≤ 0.05; ANOVA
with Dunnett’s post hoc test)
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24-h 100-μM SFN treatment. When cells were exposed to
30 μM SFN, there were significant increases in IRE1 and
EIF2α expression (Fig. 2e, f).
SFN can promote autophagy in lens cells
To examine whether SFN could induce autophagy in LEC
cells, FHL124 cells were treated with 1, 10, and 100 μM
SFN for 24 h. The level of LC3, a well-known protein asso-
ciated with autophagosome membranes, was analyzed by
Western blot. While expression of LC3-I was consistent in
all treatment groups, the level of LC3-II in cells treated with
SFN was significantly increased compared to control cells
without SFN treatment (Fig. 3a, b). To provide further evi-
dence of autophagy in response to SFN, we examined cells
using transmission electron microscopy (Fig. 3c) and immu-
nofluorescence (Fig. 3d, e). Using these methods, we could
observe increased numbers of autophagosomes in cells treated
with 10 and 100 μM SFN.
The increase of LC3-II could result from several
events, including an interruption in autophagosome–lyso-
some fusion, inhibiting lysosome-mediated proteolysis or
raising the lysosomal pH [29]. To further clarify whether
the increased level of LC3-II by SFN treatment was
caused by interrupting the autophagosome–lysosome
fusion or not, we treated FHL124 cells with 100 μM
SFN in the presence of 50 μM chloroquine (CQ) which
is a classic lysosomal inhibitor, for 6 h (Fig. 4a–d). Using
this approach, we observed a significant increase in LC3-
II levels relative to control when SFN and CQ were added
alone. Application of SFN and CQ together led to a fur-
ther significant increase. These results were also mirrored
using immunofluorescence, which demonstrated signifi-
cant changes in autophagic vesicle numbers with SFN
and CQ, which were further elevated with co-treatment.
To further assess the hypothesis that SFN can induce au-
tophagy in FHL124 cells, 3-methyladenine (3-MA) was
utilized as an early-stage autophagy inhibitor. Treatment
with 100 μM SFN induced significant increases in LC3-II
levels and autophagosome numbers. These responses
were significantly suppressed by co-treatment with
500 μM 3-MA (Fig. 4e–h).
Fig. 3 SFN can initiate autophagy in FHL124 human lens epithelial
cells. LC3-I and LC3-II levels were detected using Western blot
methods following 24-h exposure to increasing concentrations of SFN
(a, b); a representative blot showing products for LC3-I and LC3-II at 18
and 16 kDa (a) and quantitative data (b) are displayed. Data are presented
as mean ± SEM (n = 4). Asterisk indicates a significant difference
between treated and nontreated control groups (p ≤ 0.05; ANOVA with
Dunnett’s post hoc test). Transmission electron micrographs demonstrate
the ultrastructure of cells treated with 100 μM SFN (b). A number
of autophagic vesicles can be clearly seen with SFN treatment.
Fluorescence micrographs showing LC3 distribution in association
with autophagic vesicles in control and 100 μM SFN-treated cells (c, d);
representative images (c) and quantitative data pooled from three
separate experiments (d) are presented. Data are presented as
mean ± SEM. Asterisk indicates a significant difference between the
treated group and untreated controls (p ≤ 0.05; ANOVAwith Dunnett’s
post hoc test)
Fig. 4 Chloroquine and 3-MA disrupt SFN-induced autophagy
responses in FHL124 human lens epithelial cells. LC3 levels detected
using Western blot methods and autophagic vesicle formation in
response to 100 μM SFN treatment in the presence and absence of
50 μM chloroquine (a–d) and 500 μM 3-MA (e–h). Western blots
detected products for LC3-I and LC3-II at ∼18 and 16 kDa; a band
corresponding to β-actin was detected at 45 kDa. Data are presented as
mean ± SEM (n = 3). Asterisk indicates a significant difference from all
other groups (p ≤ 0.05; ANOVAwith Tukey’s post hoc test)
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MAPK signaling is critical for SFN-induced autophagy
The mitogen-activated protein kinases (MAPKs) have been
reported to promote autophagy as downstream mediators of
ROS [28]. Therefore, we analyzed the level of several phos-
phorylated MAPKs including p38, c-Jun N-terminal kinase
(JNK), and ERK by immunoblotting to examine if MAPKs
are involved in SFN-induced autophagy in FHL124 cells. One
hundred micromolars SFN did not induce a detectable change
in the level of phospho-specific p38 at any time point tested. A
significant but relatively weak increase in pJNK level was
observed at the 24-h time point. In contrast, levels of phos-
phorylated ERK1/2 (pERK) in cells treated with SFN
(100 μM) showed significant increases at 6-, 12-, and 24-h
time points (Fig. 5a, b). This increase in ERK activation pre-
ceded detectable changes in LC3-II levels (Fig. 5a, b). These
results indicate that ERK activation might be involved in
SFN-induced autophagy. We therefore tested this notion by
disrupting ERK activation using the MEK inhibitor U0126
(Fig. 5c–f). FHL124 cells were pretreated with U0126
(5 μM) for 30 min before SFN treatment. Application of
U0126 significantly reduced SFN-induced increase in LC3-
II levels and autophagic vesicle incidence. Finally, it has been
suggested that SFN-induced activation of ERK is mediated by
ROS. We therefore determined whether SFN could induce
ROS levels in FHL124 cells. Application of 100 μM SFN
was found to significantly increase ROS relative to controls
(Fig. 6).
Discussion
The influence of SFN on the physiology of human cells has
been studied extensively in recent years, but this work has
Fig. 5 MAPK signaling
involvement in SFN-induced
autophagy in FHL124 human
lens epithelial cells. The effects of
100 μM SFN on p38, JNK, and
ERK phosphorylation in
conjunction with LC3-II levels
detected by Western blot methods
(a, b); representative blots
showing products at ∼44/42 kDa
(phospho and total ERK1/2),
46 kDa (phospho and total
JNK1), 38 kDa (phospho and
total p38), and 45 kDa (β-actin)
(a) and pooled quantitative data
(b) are presented. Data are
presented as mean ± SEM (n = 4).
Asterisk indicates a significant
difference between treated and
nontreated control groups
(p ≤ 0.05; ANOVAwith Dunnett’s
post hoc test). The influence of
inhibiting ERK phosphorylation
(using 5 μM U0126) on SFN
induced LC3-II expression (c, d)
and autophagic vesicles (e, f).
Western blots detected products
for LC3-I and LC3-II at ∼18 and
16 kDa; phospho and total
ERK1/2 were detected at ∼44/
42 kDa; a band corresponding to
β-actin was detected at 45 kDa.
Data are presented as
mean ± SEM (n = 3). Asterisk
indicates a significant difference
from all other groups (p ≤ 0.05;
ANOVAwith Tukey’s post hoc
test)
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largely focused on cancer [16, 32]. However, the functional
role of SFN in the prevention of PCO, which affects a large
proportion of cataract patients, has not been investigated. In
the present study, it was therefore deemed an important op-
portunity to test the hypothesis that SFN can inhibit the devel-
opment of PCO. Evaluation of SFN in a human lens capsular
bag model supported this notion, and the effective concentra-
tions required mirrored results obtained in a human lens epi-
thelial cell line, FHL124. This therefore suggested that the
readily available cell line could be employed to establish
mechanisms that underpin SFN-induced effects.
The present study demonstrates that SFN can induce ER
stress, which was observed by induction of ER stress gene and
protein expression. An important role of the ER is to sense
environmental and physiological stresses. This response is
mediated by activation and repression of pathways resulting
in specific functional outcomes. The ER is the site of protein
synthesis, where folding and trafficking are initiated, and also
the mediator of internal and external stresses [22]. ER stress
can arise because unfolded or misfolded proteins are produced
within the ER. Normal levels of unfolded proteins can be
counteracted by a number of ER chaperone proteins, but if
the level continues to increase, for example, through
prolonged oxidative or osmotic stress, then it is detected by
the molecule BiP, which in turn activates one or more of three
stress pathway initiators (pERK, IRE1, and ATF6). Once a
prolonged stress is sensed, then a range of external pathways
are initiated and cell death through apoptosis can result [23].
Application of the classical ER stress molecule
thapsigargin leads to an inhibition of lens cell growth and,
ultimately, to cell death through apoptosis [33, 34]. It has also
been reported that diabetic and oxidative stresses to lens cells
can give rise to an ER stress response, seen as an increase in
BiP production and caspase activation [35]. Arsenic trioxide
(As2O3) is also known to promote ER stress and can reduce
lens cell viability [36]. Combinatorial treatment with SFN and
As2O3 or other known ER stressors such as thapsigargin has
been employed in the management of different cancers [26,
27] and therefore might provide a promising therapeutic ap-
proach for PCO.
It has been suggested that SFN can increase ROS produc-
tion [20, 28], and in the current study, we confirm that lens
cells show elevated ROS levels in response to SFN.
Interestingly, as discussed above, SFN exposure in combina-
tion with As2O3 can result in a dramatic increase in levels of
ROS compared to treatment with either agent alone [26]. SFN,
alone or with As2O3, decreased intracellular glutathione
(GSH) content. Furthermore, addition of the free radical scav-
enger N-acetyl-L-cysteine (NAC) rescued cells from As2O3/
isothiocyanate-mediated cytotoxicity [26]. As As2O3 has been
associated with ER stress in the lens and investigated for its
potential benefits in the prevention of PCO [36], this suggests
that SFN deserves further investigation in combination with
As2O3 in the treatment of PCO and it will be interesting to
establish the role of ROS in SFN-induced ER stress.
Autophagy is a highly controlled process that can be affect-
ed by several conditions such as metabolic stress, ER stress,
oxidative stress, and hypoxia [37]. The process of autophagy
involves the formation of double-membraned vesicles
(autophagosomes), which encapsulate the cytoplasm and or-
ganelles and fuse with lysosomes, leading to degradation of
the contents of the vesicle. It has been associated with specific
pathologies including cancer, liver disease, and neurodegen-
eration by a growing number of studies [38]. Brennan et al.
[39] established that autophagy occurs in normal human lens
cells, with 42 autophagy genes expressed and a number of
autophagosomal proteins detected in both the lens epithelium
and fibers. The housekeeping role of autophagy may be par-
ticularly important in normal lens maintenance, homeostasis,
and fiber differentiation [40, 41]. The loss of lens-specific
autophagy-related 5 (Atg5) has been reported to result in
age-related cataract formation, and Pik3c3/Vps34 genes are
shown to leading cortical cataract in lens [42]. In the present
study, we clearly show that SFN is capable of promoting au-
tophagy flux, which occurs in association with reduced via-
bility and increased cell death.
With respect to PCO, previous work using in vitro canine
lens capsular bags has indicated that cyclosporine A (CsA)-
induced cell loss is attributed to an autophagy-related mode of
cell death rather than classical apoptosis [43]. While autopha-
gy is typically linked to general maintenance of cells, its rela-
tionship with cell death is beginning to emerge [29] and fur-
ther investigation of the links between cell death and autoph-
agy in response to SFN will be of interest in the future.
ERK is a member of the MAPK family that is involved in
many aspects of cell biological functions such as proliferation,
Fig. 6 SFN can increase ROS production in FHL124 human lens
epithelial cells. The effect of 100 μM SFN on ROS production was
detected 2 h following initial exposure. Data are presented as
mean ± SEM (n = 4). Asterisk indicates a significant difference between
treated and nontreated control groups (p ≤ 0.05; Student’s t test)
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migration, differentiation, and death [44, 45]. MAPKs such as
p38, ERK, and JNK have been found to have downstream
effects of ROS in autophagy induction [46, 47]. Here, we
showed that SFN can induce ROS and activate ERK, which
in turn facilitates autophagy in human lens epithelial cells. It is
speculated that SFN generates ROS, which could activate
ERK. A link between ROS and ERK activation is recognized,
and it is proposed that this event could occur through several
putative mechanisms [48]. One possibility is the activation of
upstream growth factor receptors, such as EGF receptor,
which have been reported to be activated in response to oxi-
dative stress [49]. EGFR is expressed in both FHL124 cells
and the native lens. It is also possible that ROS could alter
protein structure of signaling molecules and in doing so pro-
mote signaling activity [48]. It is also feasible that MAPK
phosphatases, the negative regulators of MAPK signaling,
are deactivated and degraded by ROS [48]. Removal of this
negative regulator would therefore enable persistent activation
of ERK to take place and may best explain the results ob-
served. Signaling mediated through ERK is often associated
with growth and survival, but it is also linked to death path-
ways [45]. It has been suggested that ERK activity can play a
role in mediating extrinsic and intrinsic apoptotic pathways. In
the case of SFN treatment, sustained ERK activity is likely to
facilitate promotion of the intrinsic apoptotic pathway that is
associated with release of pro-apoptotic factors from the mi-
tochondrion that will lead to caspase-9 activation, which will
then activate caspase3/7 [45]. The role of ERK in autophagy is
also very interesting. Autophagy itself serves an important
role in cell maintenance but in some cases can itself lead to
cell death [29, 45]. The mode of cell death could be through
conventional apoptosis, but it is also often reported that a
distinct autophagy-induced cell death can arise that not only
has some features common with conventional apoptosis but
also presents distinct morphological changes leading to death.
It will be of great interest to tease out the relationship between
ROS, ERK, and cell death using free radical scavengers and
MEK inhibitors to achieve this.
Considering the data as a whole, it is possible to speculate
on the sequence of events that may take place following SFN
application that ultimately lead to cell death. The primary
initiating event is likely to be the generation of free radicals
within the cell that will result in an oxidative stress that trig-
gers an ER stress response and promote ERK activity. These
two events are both known to stimulate autophagy, and, thus,
increased breakdown of cellular material will result. ER stress
is associated with reduced protein synthesis, and, thus, a re-
stricted capacity to replace damaged organelles will compro-
mise the cells and trigger death pathways. Sustained ERK
activity is likely to deplete mitochondrial numbers, which will
in turn activate caspase-mediated cell death. Similarly, a
sustained ER stress could also promote caspase-mediated cell
death pathways.
In summary, we have shown that SFN can reduce lens cell
viability in both a human lens cell line and a tissue culture
model, which has implications for the treatment of PCO.
Moreover, we have demonstrated for the first time that SFN
can promote ER stress and autophagy in lens cell. SFN-
induced autophagy requires MAPK signaling, and we specu-
late that both ER stress and autophagy are regulated by ROS
production.
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